| IL-10 | Fluorocitrate | Minocycline | Saline |
---|
 |
Vi/Vc
|
Vc
|
Vi/Vc
|
Vc
|
Vi/Vc
|
Vc
|
Vi/Vc
|
Vc
|
Masseter-CFA
| Â | Â | Â | Â | Â | Â | Â | Â |
Ipsilateral | + | + | + | + | + | + | - | - |
Contralateral | + | - | + | - | + | - | - | - |
Skin-CFA
| Â | Â | Â | Â | Â | Â | Â | Â |
Ipsilateral | - | + | - | + | - | + | - | - |
Contralateral | - | - | - | - | - | - | - | - |
Naive
| Â | Â | Â | Â | Â | Â | Â | Â |
Ipsilateral | - | - | - | - | - | - | - | - |
Contralateral | - | - | - | - | - | - | - | - |
- Plus signs (+) indicate significant attenuation of hyperalgesia. Minus signs (-) indicate a lack of effect on hyperalgesia. Note that intra-Vi/Vc injection of the three agents attenuated bilateral hyperalgesia associated with masseter inflammation without an effect on cutaneous hyperalgesia. Intra-Vc injection of the three agents only attenuated ipsilateral hyperalgesia after both masseter and cutaneous inflammation.